FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Zynex Files 510(k) for CO-Oximeter Device

[ Price : $8.95]

Zynex files a 510(k) for its NiCO, Noninvasive CO-Oximeter device that relies on the companys laser technology.

48 New, Revised PSGs Out

[ Price : $8.95]

FDA publishes 34 new and 14 revised product-specific guidances to aid in generic drug development.

Miller Named Acting Inspections Chief

[ Price : $8.95]

FDA names Elizabeth Miller acting associate commissioner of the Office of Inspections and Investigations (OII), replacing Michael ...

FDA Warns Sarfez About Soaanz Promotional Materials

[ Price : $8.95]

The CDER Office of Prescription Drug Promotion warns Sarfez Pharmaceuticals that promotional materials for its Soaanz edema drug c...

Covid Vaccine Policy on Boosters and New Trials

[ Price : $8.95]

FDA commissioner Marty Makary and CBER director Vinay Prasad outline a new regulatory framework for annual Covid-19 booster shots...

SSRI/SNRI Labeling Changes Sought

[ Price : $8.95]

The Antidepressant Coalition for Education petitions FDA to change labeling for selective serotonin reuptake inhibitors and seroto...

FDA Approves Bayers Jivi Antihemophilic Factor

[ Price : $8.95]

FDA expands its approval of Bayers Jivi for the routine prophylactic treatment of hemophilia A in previously treated adult and ped...

Panel Wants More U.S. Patient Data on Glofitamab

[ Price : $8.95]

FDAs Oncologic Drugs Advisory Committee says there are insufficient number of U.S.-treated patients in a clinical trial supporting...

PDUFA Public Meeting for User Fee Reauthorization

[ Price : $8.95]

Federal Register notice: FDA announces a 7/14 public meeting to discuss proposed recommendations for the reauthorization of the Pr...

Generic Drug Fee Program Reauthorization Meeting

[ Price : $8.95]

Federal Register notice: FDA hosts a 7/11 public meeting on the reauthorization of the Generic Drug User Fee Amendments (GDUFA) fo...